Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Two Doses of ELMIRON in Interstitial Cystitis
NCT00086684Phase 4Terminated
- Sponsor
- Johnson & Johnson
- Start
- Sep 2003
- Primary completion
- Jun 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of pentosan polysulfate sodium in interstitial cystitis (IC) (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Number of Responders Defined as Having at Least a 30% Reduction in the O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) at 24 weeks. Started Sep 2003; status: terminated.
02
Drugs
pentosan polysulfate sodium
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00086684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086684.